The following tables summarize the amortized cost, unrealized gains (losses) and fair value of available-for-sale marketable securities (in thousands):


	March 31, 2026
	Amortized Cost			Unrealized Gains		Unrealized Losses			Fair Value
Money market funds	$	23,503		$	—	$	—		$	23,503
U.S. government bonds		59,666			40		(47	)		59,659
Government agency obligations		18,285			26		(5	)		18,306
Corporate debt obligations		18,740			—		(40	)		18,700
Commercial paper		18,209			2		(20	)		18,191
Total		138,403			68		(112	)		138,359
Less: amounts classified as cash equivalents		(23,503	)		—		—			(23,503	)
Total available-for-sale marketable securities	$	114,900		$	68	$	(112	)	$	114,856


	December 31, 2025
	Amortized Cost			Unrealized Gains		Unrealized Losses			Fair Value
Money market funds	$	40,721		$	—	$	—		$	40,721
U.S. government bonds		72,006			172		(1	)		72,177
Government agency obligations		15,762			63		—			15,825
Corporate debt obligations		15,201			10		—			15,211
Commercial paper		15,848			16		—			15,864
Total		159,538			261		(1	)		159,798
Less: amounts classified as cash equivalents		(40,721	)		—		—			(40,721	)
Total available-for-sale marketable securities	$	118,817		$	261	$	(1	)	$	119,077

As of March 31, 2026 and December 31, 2025, no significant facts or circumstances were present to indicate a deterioration in the creditworthiness of the issuers of the available-for-sale securities, and the Company has no requirement or intention to sell these securities before maturity or recovery of their amortized cost basis. The Company considered the current and expected future economic and market conditions and determined that its investments were not significantly impacted. For all securities with a fair value less than its amortized cost basis, the Company determined the decline in fair value below amortized cost basis to be immaterial and non-credit related, and therefore no allowance for losses has been recorded. During the three months ended March 31, 2026 and 2025, the Company did not recognize any impairment losses on its investments.

Accrued interest receivable included in prepaid expenses and other current assets as of March 31, 2026 and December 31, 2025 was $1.0 million and $1.2 million, respectively. The Company has not written off any accrued interest receivable during the three months ended March 31, 2026 and 2025.

The amortized cost and fair value of available-for-sale marketable securities by contractual maturity were as follows (in thousands):


	March 31, 2026				December 31, 2025
	Amortized Cost		Fair Value		Amortized Cost		Fair Value
Maturing within one year	$	109,867	$	109,839	$	112,777	$	113,038
Maturing in one to five years		5,033		5,017		6,040		6,039
Total available-for-sale marketable securities	$	114,900	$	114,856	$	118,817	$	119,077